HealthcareServices

Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Industry Insights: Key Trends and Growth Estimates

February 20, 2026February 20, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the bioinformatics in in-vitro diagnostics (ivd) testing market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market from 2026 to 2030?

The bioinformatics in in-vitro diagnostics (ivd) testing market size has experienced strong growth in recent years. It is anticipated to expand from $98.89 billion in 2025 to $105.59 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.8%. The market’s historical growth can be attributed to the increasing volumes of molecular diagnostic testing, the rising adoption of next-generation sequencing in diagnostics, the proliferation of centralized diagnostic laboratories, the availability of advanced diagnostic hardware, and the greater use of data-driven clinical decision support.

The bioinformatics in in-vitro diagnostics (ivd) testing market is projected for substantial expansion in the coming years. This market is anticipated to reach $133.49 billion by 2030, showing a compound annual growth rate (CAGR) of 6.0%. This anticipated growth over the forecast period stems from several factors, including the surging need for precision diagnostics, the broadening scope of personalized medicine diagnostics, heightened investments in AI-powered diagnostic platforms, the expanding application of cloud-based diagnostic analytics, and greater regulatory endorsement of digital diagnostics. Key trends during this period encompass the increasing deployment of AI-driven diagnostic interpretation software, the heightened embrace of cloud-enabled IVD bioinformatics platforms, the growing consolidation of molecular and clinical data, the broadening of companion diagnostics analytics, and a stronger emphasis on processing diagnostic data in real-time.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16629&type=smp

What Drivers Are Affecting Demand In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?

The rising incidence of cancer is anticipated to fuel the expansion of bioinformatics within the IVD testing market in the future. Cancer itself is a collective term for conditions marked by uncontrolled cell proliferation, capable of invading and metastasizing throughout the body. This growing prevalence of cancer stems from diverse factors including environmental exposures, lifestyle choices, and other external influences. In the realm of IVD testing, bioinformatics revolutionizes cancer diagnostics by delivering accurate, tailored, and exhaustive genetic data, thereby improving early diagnosis, guiding therapeutic choices, and ultimately bettering patient prognoses. As an illustration, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported in February 2024 that over 35 million new cancer cases are predicted in 2050. Consequently, the escalating occurrence of cancer acts as a primary catalyst for the bioinformatics sector within the IVD testing market.

Which Segment Groups Are Influencing The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?

The bioinformatics in in-vitro diagnostics (ivd) testing market covered in this report is segmented –

1) By Component: Hardware, Software

2) By Type Of Test: Blood Based Tests, Tissue Based Tests

3) By Application: Cardiovascular Diseases, Chronic Diseases, Diabetes, Cancer, Other Applications

Subsegments:

1) By Hardware: Analyzers, Laboratory Equipment, Data Storage Devices, Sensors And Detectors, Workstations And Data Processing Hardware

2) By Software: Bioinformatics Platforms, Data Management and Integration Software, Analytics And Interpretation Software, Cloud-Based Software Solutions, AI-Based Software For Diagnostics

What Trends Are Projected To Support The Growth Of The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?

Companies operating within the bioinformatics in the IVD testing market are concentrating on developing innovative solutions, such as next-generation sequencing (NGS) technology. These advancements aim to enhance the detection and analysis of genetic mutations, improve diagnostic accuracy, and facilitate personalized medicine approaches. Next-generation sequencing (NGS) itself is a high-throughput technology that enables the rapid sequencing of entire genomes or specific DNA and RNA regions, allowing for comprehensive genetic analysis. For example, in January 2024, QIAGEN Digital Insights, the bioinformatics division of the Netherlands-based molecular diagnostics company QIAGEN, introduced LightSpeed. This ultra-fast NGS (next-generation sequencing) secondary-analysis software accelerator is integrated into its CLC Genomics Workbench Premium platform. The LightSpeed module allows laboratories to process somatic cancer NGS data with unprecedented speed, converting raw sequencing files (FASTQ) into variant calls (VCF) in just minutes, while simultaneously reducing the cost per sample. LightSpeed supports high-throughput cancer panels and is compatible with both cloud-based and on-premises workflows, empowering bioinformatics teams to quickly analyze multiple tumor genes and biomarkers from a single sample to guide precision oncology decision-making.

Who Are The Major Companies Operating In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?

Major companies operating in the bioinformatics in in-vitro diagnostics (ivd) testing market are Illumina Inc, Thermo Fisher Scientific Inc, QIAGEN N.V, Agilent Technologies Inc, PerkinElmer Inc, Roche Holding AG, BGI Genomics Co Ltd, DNAnexus Inc, Seven Bridges Genomics Inc, Dassault Systèmes SE (BIOVIA), Genedata AG, Partek Inc, Data4Cure Inc, Ontoforce NV, Geneious (Biomatters), SoftGenetics LLC, Eagle Genomics Ltd, Wuxi NextCODE Genomics, Bio‑Rad Laboratories Inc, Eurofins Scientific SE

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/bioinformatics-in-in-vitro-diagnostics-ivd-testing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?

North America was the largest region in the bioinformatics in in-vitro diagnostics (IVD) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioinformatics in in-vitro diagnostics (ivd) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16629&type=smp

Browse Through More Reports Similar to the Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market 2026, By The Business Research Company

Biologics Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

In Vitro Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

In Vitro Diagnostics Ivd Quality Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info